131 related articles for article (PubMed ID: 2882083)
1. Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease.
Raju TN; Vidyasagar D; Bhat R; Sobel D; McCulloch KM; Anderson M; Maeta H; Levy PS; Furner S
Lancet; 1987 Mar; 1(8534):651-6. PubMed ID: 2882083
[TBL] [Abstract][Full Text] [Related]
2. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
3. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
4. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants.
Kwong MS; Egan EA; Notter RH; Shapiro DL
Pediatrics; 1985 Oct; 76(4):585-92. PubMed ID: 3900906
[TBL] [Abstract][Full Text] [Related]
5. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.
Vidyasagar D; Maeta H; Raju TN; John E; Bhat R; Go M; Dahiya U; Roberson Y; Yamin A; Narula A
Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883
[TBL] [Abstract][Full Text] [Related]
6. Effect of exogenous surfactant on the development of bronchopulmonary dysplasia in a baboon hyaline membrane disease model.
Maeta H; Raju TN; Vidyasagar D; Bhat R; Esterly J; Matsuda H; Shimada S; Krukenkamp IB; Shanklin DR
Crit Care Med; 1990 Apr; 18(4):403-9. PubMed ID: 2318051
[TBL] [Abstract][Full Text] [Related]
7. Hyaline membrane disease treated with bovine surfactant.
Smyth JA; Metcalfe IL; Duffty P; Possmayer F; Bryan MH; Enhorning G
Pediatrics; 1983 Jun; 71(6):913-7. PubMed ID: 6687937
[TBL] [Abstract][Full Text] [Related]
8. Exogenous surfactant replacement therapy of hyaline membrane disease in premature infants.
Namgung R; Lee C; Suh JS; Park KI; Han DG
Yonsei Med J; 1989 Dec; 30(4):355-66. PubMed ID: 2697112
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
Gitlin JD; Soll RF; Parad RB; Horbar JD; Feldman HA; Lucey JF; Taeusch HW
Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835
[TBL] [Abstract][Full Text] [Related]
10. Effect of single dose surfactant on pulmonary function.
Bhat R; Dziedzic K; Bhutani VK; Vidyasagar D
Crit Care Med; 1990 Jun; 18(6):590-5. PubMed ID: 2111754
[TBL] [Abstract][Full Text] [Related]
11. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME
Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
[TBL] [Abstract][Full Text] [Related]
12. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
[TBL] [Abstract][Full Text] [Related]
13. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.
Couser RJ; Ferrara TB; Ebert J; Hoekstra RE; Fangman JJ
J Pediatr; 1990 Jan; 116(1):119-24. PubMed ID: 2404097
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of severe hyaline membrane disease with a single-dose of natural exogenous surfactant of porcine origin. A randomized trial: immediate effects and outcome at 28 days of life].
Walti H; Relier JP; Huon C; Monset-Couchard M; Scemama M; De Gamarra E; Moriette G; Curstedt T; Robertson B
Arch Fr Pediatr; 1990 May; 47(5):329-34. PubMed ID: 2196030
[TBL] [Abstract][Full Text] [Related]
15. Surfactant therapy and spontaneous diuresis.
Bhat R; John E; Diaz-Blanco J; Ortega R; Fornell L; Vidyasagar D
J Pediatr; 1989 Mar; 114(3):443-7. PubMed ID: 2646416
[TBL] [Abstract][Full Text] [Related]
16. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
[TBL] [Abstract][Full Text] [Related]
17. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
[TBL] [Abstract][Full Text] [Related]
18. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
[TBL] [Abstract][Full Text] [Related]
19. Animal derived surfactant extract for treatment of respiratory distress syndrome.
Seger N; Soll R
Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
[TBL] [Abstract][Full Text] [Related]
20. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
